DNMT1 and esophageal squamous cell carcinoma: The use of a DNMT inhibitor reduced EMT and improved chemotherapy sensitivity in ESCC cell models, suggesting that mechanisms aiming to restore mtDNA-CN content represent a paradigm shift in therapeutic strategies for cancers [67].